Exploiting the Annexin A1 pathway for the development of novel anti‐inflammatory therapeutics
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The appreciation that the inflammatory reaction does not ‘spontaneously’ finish, but rather that inflammatory resolution is an active phenomenon brought about by endogenous anti‐inflammatory agonists opens multiple opportunities for a reassessment of the complexity of inflammation and its main mediators. This review dwells on one of these pathways, the one centred around the glucocorticoid‐regulated protein Annexin A1 and its G protein‐coupled receptor. In recent years, much of the knowledge detailing the processes by which Annexin A1 expresses its anti‐inflammatory role on innate immunity has been produced. Moreover, the generation of the Annexin A1 null mouse colony has provided important proof‐of‐concept experiments demonstrating the inhibitory properties of this mediator in the context of inflammatory and/or tissue‐injury models. Therefore, Annexin A1 acts as a pivotal homeostatic mediator, where if absent, inflammation would overshoot and be prolonged. This new understanding scientific information could guide us onto the exploitation of the biological properties of Annexin A1 and its receptor to instigate novel drug discovery programmes for anti‐inflammatory therapeutics. This line of research relies on the assumption that anti‐inflammatory drugs designed upon endogenous anti‐inflammatory mediators would be burdened by a lower degree of secondary effects as these agonists would be mimicking specific pathways activated in our body for safe disposal of inflammation. We believe that the next few years will produce examples of such new drugs and the validity of this speculation could then be assessed. This article is part of a themed issue on Mediators and Receptors in the Resolution of Inflammation. To view this issue visit http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2009
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354 · cited 3×
“) Lim et al. (1998) ↑ Detachment of adherent leukocytes (i.v.) Intestinal ischaemia–reperfusion (mouse) ↓ Tissue injury Souza et al. (2007) ↓ TNF-a levels ↓ Lethality Neutrophil/endothelial interaction under flow (human cells) ↓ PMN adhesion Hayhoe et al.”
BackgroundInfluentialPoints of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Annexins: From Structure to Function
Gerke, V., & Moss, S. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00030.2001 · Cited by 2,029
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045
Self-citationAnnexin A1 and glucocorticoids as effectors of the resolution of inflammation
Perretti, M., & D'Acquisto, F. (2009) · Nature Reviews Immunology · doi:10.1038/nri2470 · Cited by 915
Self-citationCroxtall, J. D., Choudhury, Q., & Flower, R. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703272 · Cited by 332
Amyloid β42Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1
Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N. M., Gao, J.-L., Murphy, P. M., Oppenheim, J. J., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0003.2001 · Cited by 270
Annexin-1 modulates T-cell activation and differentiation
D'Acquisto, F., Merghani, A., Lecona, E., Rosignoli, G., Raza, K., Buckley, C. D., Flower, R. J., & Perretti, M. (2007) · Blood · doi:10.1182/blood-2006-05-022798 · Cited by 195 · cited 1×
“Lymphocytes have modest expression of Annexin A1, with T cells being positive for the protein (although with nearly a 1:100 the expression observed in neutrophils), whereas B cells (Morand et al., 1995; Mulla et al., 2005; D’Acquisto et al., 2007; Perretti et al., 2009) and platelets are negative for Annexin A1 expres…”
BackgroundSelf-citationAnnexin A1 regulates intestinal mucosal injury, inflammation, and repair
Babbin, B. A., Laukoetter, M. G., Nava, P., Koch, S., Lee, W. Y., Capaldo, C. T., Peatman, E., Severson, E. A., Flower, R. J., Perretti, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5035 · Cited by 134 · cited 1×
“, 2007) and a delayed repair in a model of colitis (Babbin et al., 2008) (Table 2).”
BackgroundSelf-citation
Research works printed but not linked: 108
- 10.1074/jbc.M513025200 · DOI · Paper page
- 10.1124/jpet.104.080473 · doi:10.1124/jpet.104.080473
- 10.1038/287147a0 · DOI · Paper page
- 10.1016/0006-291X(90)91143-G · DOI · Paper page
- 10.1021/bi00502a016 · DOI · Paper page
- 10.1016/j.bmcl.2006.04.068 · DOI
- 10.1152/ajpcell.1990.259.2.C266 · DOI · Paper page
- 10.1189/jlb.0405206 · DOI · Paper page
- 10.1124/pr.58.3.4 · DOI · Paper page
- Christmas P, 1991, Selective secretion of annexin I, a protein without a signal sequence, by the human prostate gland, J Biol Chem, 266, 2499, 10.1016/S0021-9258(18)52272-9 · doi:10.1016/s0021-9258(18)52272-9
- 10.1038/328270a0 · doi:10.1038/328270a0
- 10.1073/pnas.86.9.3428 · doi:10.1073/pnas.86.9.3428
- 10.1111/j.1476-5381.1993.tb12843.x · doi:10.1111/j.1476-5381.1993.tb12843.x
- 10.1073/pnas.89.8.3571 · DOI
- 10.1038/sj.bjp.0701679 · DOI
- 10.4049/jimmunol.159.10.5089 · DOI
- 10.1093/rheumatology/ken062 · DOI
- 10.1038/bjp.2008.252 · DOI · Paper page
- 10.1096/fj.99-0602fje · DOI · Paper page
- 10.1182/blood-2008-02-140533 · DOI · Paper page
- 10.1016/S0167-4838(99)00081-3 · doi:10.1016/s0167-4838(99)00081-3
- 10.1016/S0002-9440(10)62471-6 · DOI
- 10.4049/jimmunol.176.7.4410 · DOI · Paper page
- 10.1186/ar1153 · DOI
- 10.1111/j.1476-5381.1991.tb12122.x · DOI · Paper page
- 10.1002/art.21350 · DOI · Paper page
- 10.4049/jimmunol.172.12.7669 · DOI · Paper page
- 10.1111/j.1476-5381.1989.tb12561.x · doi:10.1111/j.1476-5381.1989.tb12561.x
- 10.1016/0167-4889(85)90027-8 · doi:10.1016/0167-4889(85)90027-8
- 10.1038/sj.bjp.0701211 · DOI · Paper page
- 10.1007/BF01982616 · DOI
- 10.1111/j.1476-5381.1988.tb11614.x · DOI · Paper page
- 10.1038/278456a0 · DOI · Paper page
- 10.1016/j.bmcl.2007.09.043 · doi:10.1016/j.bmcl.2007.09.043
- 10.1189/jlb.0905498 · DOI · Paper page
- 10.1016/S0014-4827(03)00055-7 · DOI · Paper page
- 10.2353/ajpath.2009.080342 · DOI
- 10.1182/blood-2002-11-3411 · DOI · Paper page
- 10.1096/fj.04-2178fje · DOI
- 10.1096/fj.06-7842com · DOI · Paper page
- 10.1038/nrm1661 · DOI · Paper page
- 10.1038/sj.bjp.0701029 · DOI
- 10.1016/j.coph.2005.02.006 · DOI
- 10.1038/nrd1383 · DOI · Paper page
- 10.1042/bst0181237 · doi:10.1042/bst0181237
- 10.1002/art.1780351126 · doi:10.1002/art.1780351126
- 10.1136/ard.54.10.841 · doi:10.1136/ard.54.10.841
- 10.1042/bj3160593 · DOI
- 10.1096/fj.02-0239fje · DOI · Paper page
- 10.1182/blood-2005-08-3099 · DOI · Paper page
- 10.1124/jpet.108.145821 · DOI
- 10.1016/j.tem.2004.02.001 · DOI
- 10.1096/fj.06-7299com · DOI
- 10.1590/S0074-02762005000900008 · DOI
- 10.1189/jlb.0305153 · DOI
- 10.1096/fj.01-0196com · DOI
- 10.1016/S0014-2999(01)01325-5 · DOI
- 10.1016/S1471-4906(02)02316-5 · DOI · Paper page
- 10.1073/pnas.95.24.14535 · DOI · Paper page
- 10.1097/nen.0b013e3181567d59 · DOI
- 10.1016/S1074-7613(01)00229-1 · DOI · Paper page
- 10.4049/jimmunol.174.6.3727 · DOI · Paper page
- 10.1152/ajpgi.00531.2007 · DOI
- Miotla JM, 1995, Suppression of experimental acute lung injury in the mouse by dexamethasone and the role of lipocortin‐1, Br J Pharmacol, 114, 62P
- 10.1006/clin.1995.1115 · DOI
- 10.1016/0968-0004(90)90186-F · DOI · Paper page
- 10.1210/jc.2004-1230 · DOI · Paper page
- 10.1038/labinvest.3780150 · doi:10.1038/labinvest.3780150
- 10.1080/09629350210000015683 · DOI
- 10.1007/s00011-008-7222-7 · DOI
- 10.1042/bj20031114 · doi:10.1042/bj20031114
- 10.1111/j.1476-5381.1993.tb13441.x · doi:10.1111/j.1476-5381.1993.tb13441.x
- 10.1016/S0165-6147(97)90674-X · DOI
- Perretti M, 1993, Modulation of IL‐1‐induced neutrophil migration by dexamethasone and lipocortin 1, J Immunol, 150, 992, 10.4049/jimmunol.150.3.992 · DOI · Paper page
- 10.4049/jimmunol.151.8.4306 · DOI · Paper page
- 10.1111/j.1476-5381.1996.tb16709.x · DOI
- 10.1038/nm1196-1259 · DOI · Paper page
- 10.1016/S0002-9440(10)64667-6 · DOI
- 10.1038/nm786 · DOI · Paper page
- 10.1084/jem.174.2.305 · DOI · Paper page
- 10.4049/jimmunol.169.3.1500 · DOI
- 10.1073/pnas.022652999 · DOI · Paper page
- 10.1016/S0014-2999(03)01314-1 · doi:10.1016/s0014-2999(03)01314-1
- 10.1038/sj.bjp.0706211 · DOI
- 10.1006/jmbi.2000.4423 · DOI
- 10.1006/jmbi.2000.4358 · DOI
- 10.4049/jimmunol.178.7.4595 · DOI · Paper page
- 10.1111/j.1365-2222.2006.02570.x · DOI
- 10.1074/jbc.M805181200 · DOI
- 10.1002/ijc.22639 · DOI
- Solito E, 1998, Human annexin 1 is highly expressed during differentiation of the epithelial cell line A549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1, Cell Growth Differ, 9, 327
- 10.1006/cyto.1997.0325 · DOI
- 10.4049/jimmunol.165.3.1573 · DOI · Paper page
- 10.1096/fj.05-5319fje · DOI
- 10.1016/j.tips.2007.12.003 · DOI
- 10.4049/jimmunol.179.12.8533 · DOI · Paper page
- 10.4049/jimmunol.166.7.4678 · DOI · Paper page
- 10.1084/jem.189.2.395 · DOI · Paper page
- 10.4049/jimmunol.181.4.2813 · DOI
- 10.1038/sj.bjp.0701625 · doi:10.1038/sj.bjp.0701625
- 10.1016/0167-4889(94)90292-5 · doi:10.1016/0167-4889(94)90292-5
- 10.1074/jbc.M702876200 · DOI
- 10.1038/320077a0 · DOI · Paper page
- 10.1016/S1097-2765(00)80323-8 · DOI · Paper page
- 10.1023/A:1027330021479 · DOI
- 10.1002/1529-0131(199907)42:7<1538::AID-ANR29>3.0.CO;2-3 · DOI · Paper page
- 10.1002/art.20201 · DOI · Paper page
- 10.1096/fasebj.14.3.572 · DOI
Cited by
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
The Neutrophil’s Role During Health and Disease
Liew, P. X., & Kubes, P. (2019) · Physiological Reviews · doi:10.1152/physrev.00012.2018 · Cited by 1,175
More friend than foe: the emerging role of neutrophils in tissue repair
Peiseler, M., & Kubes, P. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124616 · Cited by 423
“Glucocorticoids, potent antiinflammatory drugs, operate by increasing annexin A1 synthesis (133) and promote the relocation of annexin A1 to the cell surface, leading to neutrophil apoptosis, which increases the capacity of macrophage efferocytosis (134–136).”
Sugimoto, M. A., Vago, J. P., Teixeira, M. M., & Sousa, L. P. (2016) · Journal of Immunology Research · doi:10.1155/2016/8239258 · Cited by 414
Fredman, G., Kamaly, N., Spolitu, S., Milton, J., Ghorpade, D., Chiasson, R., Kuriakose, G., Perretti, M., Farokhzad, O., & Tabas, I. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1065 · Cited by 357
Self-citation
Metadata
- Authors
- Perretti, M., & Dalli, J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2009-10
- Volume
- 158
- Issue
- 4
- Pages
- 936-946
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1520032219
- Cited by
- 154
- References
- 11
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploiting the Annexin A1 pathway for the development of novel anti‐inflammatory therapeutics. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00483.x
- The paper
- Perretti, M., & Dalli, J. (2009). Exploiting the Annexin A1 pathway for the development of novel anti‐inflammatory therapeutics. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00483.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.